Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05147142 · ClinicalTrials.gov registry record · NA

Low Intensity Focused Ultrasound: a New Paradigm for Depression and Anxiety

A NA study of Depression, sponsored by Ocean State Research Institute.

Active
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT05147142: Active NA study of Depression, sponsored by Ocean State Research Institute.

NCT05147142 is a NA study of Depression that is active but no longer recruiting, run by Ocean State Research Institute. The registered enrollment target is 25 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05147142, a NA study of Depression, is active but no longer recruiting, sponsored by Ocean State Research Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

Objective: Preliminary studies show that low intensity focused ultrasound (LIFU), a new type of non invasive brain stimulation, may be able to reach deep structures of the brain involved with depression and anxiety, that remain inaccessible using current forms of non-invasive brain stimulation with precision. In this study, the investigators will test if this technique can be used to change brain activity in areas that are connected to depression and anxiety symptoms. The primary objectives of this study are to test the safety and tolerability of LIFU, evaluate the feasibility of using LIFU to reduce brain activity, and evaluate the feasibility of simultaneous fMRI-LIFU. If the results of this study are positive, what the investigators learn will serve as a strong foundation for the future development of innovative treatments for a variety of psychiatric disorders. Research Procedures: 25 veterans will be recruited. Visits will take place at the VA Providence Healthcare System. During some visits, healthy and patient participants may undergo clinical and research neuroimaging, neuropsychological testing, complete questionnaires, and participate in clinical/neurological assessments. Healthy veterans will not receive LIFU and will only attend 2 study visits. Patients are expected to attend up to 8 visits over 6 weeks. However, some may require up to 6 extended follow-ups after visits 5 or 8, in which case they would attend a total of 11 or 14 visits over 6 months. Two patient visits will include the LIFU application, following FDA safety guidelines. Patients will be assigned either to an experiment in which LIFU stimulation will be delivered immediately prior to a task or to an experiment in which stimulation will be delivered during the task. Within each experiment, patients will be assigned to first receive either LIFU stimulation to the study target or anatomical control. Study staff, but not participants will know which location is being targeted in case safety c

Primary Outcome

MRI safety and monitoring will be determined through the review of clinical MRIs. The clinical MRI will be used to detect possible LIFU-induced injury including edema or other injury and microvascular damage. While the investigators believe hyperacute injury to be unlikely, scans at 24 hours and 1-week will be used to monitor for later evolving injury. If injury is detected on any participant at any stage of the study, the investigators will halt all study procedures.

Conditions Studied

Interventions

  • DEVICE Low Intensity Focused Ultrasound

Study Locations (1)

Rhode Island

  • VA Providence Healthcare System - Providence

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2021-09-28
Est. Completion 2026-03
Phase NA
Ocean State Research Institute

1 total trials

What the registry record for NCT05147142 still lists

NCT05147142 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Low Intensity Focused Ultrasound is the first listed.

NCT05147142 reports a single indexed study location in Rhode Island.

Frequently Asked Questions

What is clinical trial NCT05147142 about?

NCT05147142 is a clinical study titled "Low Intensity Focused Ultrasound: a New Paradigm for Depression and Anxiety". Objective: Preliminary studies show that low intensity focused ultrasound (LIFU), a new type of non invasive brain stimulation, may be able to reach deep structures of the brain involved with depression and anxiety, that remain inaccessible using current forms of non-invasive brain stimulation with ...

What is the current status of trial NCT05147142?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2021-09-28. Estimated completion is 2026-03.

What conditions does trial NCT05147142 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT05147142?

The interventions under investigation include: Low Intensity Focused Ultrasound (DEVICE).

Who is sponsoring clinical trial NCT05147142?

This trial is sponsored by Ocean State Research Institute, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05147142 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05147142's enrollment target sits among peer trials

25 587th of 679 higher than 87 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT05147142, the US trial registry maintained by the National Library of Medicine. NCT05147142 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.